Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …

The monkeypox virus (MPOX) is an uncommon zoonotic illness brought on by an
orthopoxvirus (OPXV). MPOX can occur with symptoms similar to smallpox. Since April 25 …

Pandemic preparedness and response have relied primarily on market dynamics to drive
development and availability of new health products. Building on calls for transformation, we …

Triple-negative breast cancer (TNBC) is the subtype of breast cancer with the poorest
outcomes, and is associated with a high risk of relapse and metastasis. The treatment …

To adequately prepare for potential hazards caused by emerging and reemerging infectious
diseases, the WHO has issued a list of high-priority pathogens that are likely to cause future …

Vaccines have proven to be the most cost-efficient and reasonable way to fight and
exterminate virulent pathogens. Vaccines can be designed using a variety of platforms …

Interleukins (ILs) are signaling molecules that are crucial in regulating immune responses
during infectious diseases. Pro-inflammatory ILs contribute to the activation and recruitment …

Vaccines remain the best approach for the prevention of infectious diseases. Protein subunit
vaccines are safe compared to live-attenuated whole cell vaccines but often show reduced …

Ever since the development of the first vaccine, vaccination has had the great impact on
global health, leading to the decrease in the burden of numerous infectious diseases …

The immune system's complexity and ongoing evolutionary struggle against deleterious
pathogens underscore the value of vaccination technologies, which have been bolstering …